These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 159913)

  • 21. Severe hypersensitivity reactions associated with allopurinol.
    Mills RM
    JAMA; 1971 May; 216(5):799-802. PubMed ID: 4252397
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypersensitivity reaction to allopurinol].
    Salinas Martín A; Méndez Abad M; Miguélez M; Díaz González L
    Aten Primaria; 1994; 14(3):694. PubMed ID: 8086592
    [No Abstract]   [Full Text] [Related]  

  • 23. Allopurinol hypersensitivity. Granular deposition of IgM at the dermal-epidermal junction.
    Utsinger PD; Young WJ
    Am J Med; 1976 Aug; 61(2):287-94. PubMed ID: 952299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma oxypurinol concentration in a patient with allopurinol hypersensitivity.
    Puig JG; Casas EA; Ramos TH; Michán AA; Mateos FA
    J Rheumatol; 1989 Jun; 16(6):842-4. PubMed ID: 2528636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allopurinol hypersensitivity.
    Vinciullo C
    Med J Aust; 1984 Sep; 141(7):449-50. PubMed ID: 6236355
    [No Abstract]   [Full Text] [Related]  

  • 26. Allopurinol-induced DRESS syndrome.
    Markel A
    Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Life-threatening adverse effects of pharmacologic antihyperuricemic therapy].
    Russmann S; Lauterburg B
    Ther Umsch; 2004 Sep; 61(9):575-7. PubMed ID: 15493119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E
    Ugeskr Laeger; 1998 Feb; 160(8):1179-80. PubMed ID: 9492630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypersensitivity to allopurinol. Efficacy of a desensitizing protocol in 3 cases].
    Domínguez Ortega J; Trindade C; Alonso Llamazares A; Castellano Bravo A; Cimarra Alvárez-Lovel M; Martínez-Cócera C
    An Med Interna; 2001 Jan; 18(1):27-8. PubMed ID: 11387841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.
    Gutiérrez-Macías A; Lizarralde-Palacios E; Martínez-Odriozola P; Miguel-De la Villa F
    BMJ; 2005 Sep; 331(7517):623-4. PubMed ID: 16166134
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypersensitivity reaction to allopurinol].
    Malè PJ; Schaer B; Posternak F
    Schweiz Med Wochenschr; 1978 May; 108(18):681-3. PubMed ID: 653331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Syndrome of allopurinol hypersensitivity. Report of a new case and review of the Spanish literature].
    Berbegal J; Morera J; Andrada E; Navarro V; Lluch V; López-Benito I
    Med Clin (Barc); 1994 Feb; 102(5):178-80. PubMed ID: 8127168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allopurinol hypersensitivity syndrome: Liver transplantation after treatment of asymptomatic hyperuricaemia].
    Miederer SE; Miederer KO
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2537-40. PubMed ID: 25423467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol].
    Choi SH; Yang SH; Song YB; Kim HJ; Seo YT; Choi DS; Moon KH; Byun JH; Yu ES
    Korean J Hepatol; 2005 Mar; 11(1):80-5. PubMed ID: 15788888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment].
    Urban T; Maquarre E; Housset C; Chouaid C; Devin E; Lebeau B
    Rev Mal Respir; 1995; 12(3):314-6. PubMed ID: 7638430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allopurinol hypersensitivity syndrome with acute generalized exanthematous pustulosis manifestations.
    Teo WL; Pang SM; Koh HY
    Cutan Ocul Toxicol; 2011 Sep; 30(3):243-4. PubMed ID: 21345152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopurinol hypersensitivity: investigating the cause and minimizing the risk.
    Stamp LK; Day RO; Yun J
    Nat Rev Rheumatol; 2016 Apr; 12(4):235-42. PubMed ID: 26416594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.
    Min HK; Lee B; Kwok SK; Ju JH; Kim WU; Park YM; Park SH
    Korean J Intern Med; 2015 Jul; 30(4):521-30. PubMed ID: 26161019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of inpatients with adverse drug reactions to allopurinol.
    Khoo BP; Leow YH
    Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.